RSIS Repository Open-access research from RSIS International journals

International Journal of Research and Scientific Innovation (IJRSI)

Recent Breakthroughs and Emerging Trends in Gullain Barre Syndrome

byMs. E. Honey; C. Prapulla

Published November 5, 2025  •  Vol. 12, Issue 10, pp. 972–979Open Access
DOI: 10.51244/IJRSI.2025.1210000085

Abstract

Guillain-Barré Syndrome (GBS) is an acute autoimmune polyneuropathy causing progressive weakness, loss of reflexes, and sensory or autonomic dysfunction. It often follows Campylobacter jejuni infection due to molecular mimicry between microbial and nerve antigens. GBS affects 1–2 per 100,000 people annually, mainly males and older adults. Subtypes include AIDP, AMAN, AMSAN, and Miller Fisher syndrome. Diagnosis relies on clinical signs, CSF analysis, and nerve conduction studies. Early treatment with IVIG or plasma exchange improves outcomes, though some patients face lasting disability or death. Supportive care, physiotherapy, and new immunotherapies enhance recovery, while infection prevention helps reduce risk.

Keywords: Polyneuropathy, Acute flaccid paralysis, Autoimmune response

JournalInternational Journal of Research and Scientific Innovation (IJRSI)
ISSN2321-2705
Volume / IssueVolume 12, Issue 10
Pages972–979
Publication dateNovember 5, 2025
DOI10.51244/IJRSI.2025.1210000085
PublisherRSIS International
LicenseOpen Access

How to cite this article

Ms. E. Honey, & C. Prapulla (2025). Recent Breakthroughs and Emerging Trends in Gullain Barre Syndrome. International Journal of Research and Scientific Innovation (IJRSI), 12(10), 972-979. https://doi.org/10.51244/IJRSI.2025.1210000085

BibTeX

@article{Ms2025,
  title   = {Recent Breakthroughs and Emerging Trends in Gullain Barre Syndrome},
  author  = {Ms. E. Honey and C. Prapulla},
  journal = {International Journal of Research and Scientific Innovation (IJRSI)},
  volume  = {12},
  number  = {10},
  pages   = {972--979},
  year    = {2025},
  doi     = {10.51244/IJRSI.2025.1210000085},
  publisher = {RSIS International}
}